AU1223161A - 2-dimethylamino-5-phenyl-3h-1, 4-benzodiazepine derivatives - Google Patents

2-dimethylamino-5-phenyl-3h-1, 4-benzodiazepine derivatives

Info

Publication number
AU1223161A
AU1223161A AU12231/61A AU1223161A AU1223161A AU 1223161 A AU1223161 A AU 1223161A AU 12231/61 A AU12231/61 A AU 12231/61A AU 1223161 A AU1223161 A AU 1223161A AU 1223161 A AU1223161 A AU 1223161A
Authority
AU
Australia
Prior art keywords
dimethylamino
phenyl
benzodiazepine derivatives
benzodiazepine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU12231/61A
Other versions
AU256748B2 (en
Inventor
Farber Sheldon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Pharmaceutical Co filed Critical Warner Lambert Pharmaceutical Co
Application granted granted Critical
Publication of AU256748B2 publication Critical patent/AU256748B2/en
Publication of AU1223161A publication Critical patent/AU1223161A/en
Expired legal-status Critical Current

Links

AU12231/61A 1961-05-29 1961-12-11 2-dimethylamino-5-phenyl-3h-1, 4-benzodiazepine derivatives Expired AU256748B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
USUS113152 1961-05-29

Publications (2)

Publication Number Publication Date
AU256748B2 AU256748B2 (en) 1963-06-13
AU1223161A true AU1223161A (en) 1963-06-13

Family

ID=

Similar Documents

Publication Publication Date Title
AU256748B2 (en) 2-dimethylamino-5-phenyl-3h-1, 4-benzodiazepine derivatives
CY417A (en) Novel 1,4-benzodiazepine derivatives
AU1223161A (en) 2-dimethylamino-5-phenyl-3h-1, 4-benzodiazepine derivatives
AU255726B2 (en) 1, 4 benzodiazepine derivatives
CA633224A (en) Modified polyamides
AU1178961A (en) 1, 4 benzodiazepine derivatives
AU281621B2 (en) 3-substituted-13, 17-dialkyl-17-hydroxy
CA620543A (en) 2-methyl-6-fluoro-1,4-pregnadienes
AU259882B2 (en) Certain 5-nitro-2-furylamidoxime derivatives
AU267910B2 (en) Nitrofurfural carbohydrazone derivatives
CA624501A (en) 3-aminoisocamphane derivatives
CA619529A (en) Amino-trifluorotoluenedisulfonamide derivatives
AU264335B2 (en) Sulphanilamido-pyrimidine derivatives
AU272405B2 (en) Phenyltetrahydropyridine derivatives
CA612438A (en) Polymethacrolein derivatives
CA616351A (en) Phenothiazine-organotin derivatives
CA617631A (en) Diphenylacetamide derivatives
CA630661A (en) Iso-benzmorphan derivatives
CA619962A (en) Metathiazanone derivatives
AU2315462A (en) 3-substituted-13, 17-dialkyl-17-hydroxy
AU270786B2 (en) 1, 4-dihydroxyanthraquinones
AU272161B2 (en) 3,5 - dihalo - amino - benzylamines
CA629026A (en) 4,7-diamino-n-aralkyl-2-aryl-6-pteridinecarboxamides
CA625561A (en) 1-acetyl-6-methoxy-9-methyl-3,4,5,6,7,8,9,10-octahydronaphthalene
AU272093B2 (en) 2, 3-alkylene-tetrahydro-guinolines